Trevi Therapeutics, Inc. TRVI Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Trevi Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed November 13, 2025, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s interest coverage?
- Trevi Therapeutics, Inc. (TRVI) reported interest coverage of -51,351× in Q3 2025.
- How has Trevi Therapeutics, Inc.'s interest coverage changed year-over-year?
- Trevi Therapeutics, Inc.'s interest coverage decreased by 645.5% year-over-year, from -6,887.9× to -51,351×.
- What is the long-term trend for Trevi Therapeutics, Inc.'s interest coverage?
- Over 4 years (2020 to 2024), Trevi Therapeutics, Inc.'s interest coverage has grown at a 297.1% compound annual growth rate (CAGR), from -51.8× to -12,881.3×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.